HLA-DRB1 and rheumatoid arthritis: In this study, we investigated the association between treatment response and individual HLA-DRB1 alleles in patients with RA using ABT, tocilizumab (TCZ, an IL-6 receptor inhibitor), or a TNF inhibitor as their first bDMARD, and attempted to identify HLA alleles associated with treatment outcome.